News Pfizer, Inc.

Equities

PFE

US7170811035

Market Closed - Nyse Other stock markets 04:00:16 2024-07-15 pm EDT			5-day change	1st Jan Change
29.1 ^USD	+0.62%		+4.19%	+1.08%

Jul. 15	Everest Medicines Announces Positive Topline Results from Maintenance Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderately-to-Severely Active Ulcerative Colitis	CI
Jul. 12	Health Care Up as Momentum Builds -- Health Care Roundup	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Everest Medicines Announces Positive Topline Results from Maintenance Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderately-to-Severely Active Ulcerative Colitis	Jul. 15	CI
Health Care Up as Momentum Builds -- Health Care Roundup	Jul. 12	DJ
UBS Raises Price Target on Pfizer to $30 From $28, Maintains Neutral Rating	Jul. 12	MT
CureVac Provides Update on Trial Dates for Patent Litigation across Multiple Geographies against Pfizer, BioNTech	Jul. 12	AQ
PFIZER INC : Receives a Buy rating from Goldman Sachs	Jul. 12	ZD
Health Care Up as Obesity-Drug Wars Continue -- Health Care Roundup	Jul. 11	DJ
Sector Update: Health Care Stocks Rise Late Afternoon	Jul. 11	MT
PFIZER INC : Jefferies keeps its Buy rating	Jul. 11	ZD
Sector Update: Health Care Stocks Advance in Afternoon Trading	Jul. 11	MT
Top Midday Stories: Bain Capital to Acquire Envestnet; Delta, Pepsi Report Q2 Earnings; Pfizer Advances Development of Weight-Loss Pill; DOE Pledges $1.7 Billion for EV	Jul. 11	MT
Sector Update: Health Care Stocks Advance Premarket Thursday	Jul. 11	MT
Sector Update: Health Care	Jul. 11	MT
CureVac Notes New Court Trial Timeline for Patent Cases Against Pfizer, BioNTech	Jul. 11	MT
Pfizer: advances in anti-obesity pill danuglipron	Jul. 11	CF
CureVac Provides Trial Dates for Patent Litigation Against Pfizer, BioNTech	Jul. 11	MT
Exchange-Traded Funds, Equity Futures Edge Lower Pre-Bell Ahead of Key Inflation Data	Jul. 11	MT
Pfizer to Advance Development of Modified-Release Formulation of Danuglipron	Jul. 11	MT
Futures edge lower ahead of inflation test; Delta Airlines falls	Jul. 11	RE
Pfizer Picks Once-Daily Obesity Pill Version for Further Study	Jul. 11	DJ
Pfizer moves forward with once-daily weight loss drug	Jul. 11	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Pfizer, Inc: A cycle for nothing?

December 14, 2023 at 10:58 am EST

Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs

October 31, 2023 at 04:50 pm EDT